UBS Group’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $141K | Sell |
13,833
-23,774
| -63% | -$256K | ﹤0.01% | 6821 |
|
|
2025
Q4 | $402K | Buy |
37,607
+3,850
| +11% | +$46.1K | ﹤0.01% | 6208 |
|
|
2025
Q3 | $461K | Sell |
33,757
-77,072
| -70% | -$1.08M | ﹤0.01% | 6156 |
|
|
2025
Q2 | $1.56M | Buy |
110,829
+44,633
| +67% | +$587K | ﹤0.01% | 5059 |
|
|
2025
Q1 | $892K | Sell |
66,196
-25,986
| -28% | -$390K | ﹤0.01% | 5376 |
|
|
2024
Q4 | $1.62M | Buy |
92,182
+85,866
| +1,359% | +$1.59M | ﹤0.01% | 4925 |
|
|
2024
Q3 | $121K | Sell |
6,316
-4,905
| -44% | -$94.5K | ﹤0.01% | 6225 |
|
|
2024
Q2 | $245K | Sell |
11,221
-112,580
| -91% | -$3M | ﹤0.01% | 5530 |
|
|
2024
Q1 | $4.74M | Buy |
123,801
+31,757
| +35% | +$1.54M | ﹤0.01% | 3034 |
|
|
2023
Q4 | $6.19M | Buy |
92,044
+16,260
| +21% | +$1.13M | ﹤0.01% | 2544 |
|
|
2023
Q3 | $5.67M | Buy |
75,784
+5,309
| +8% | +$471K | ﹤0.01% | 2449 |
|
|
2023
Q2 | $6.49M | Buy |
70,475
+60,978
| +642% | +$5.43M | ﹤0.01% | 2334 |
|
|
2023
Q1 | $985K | Buy |
9,497
+76
| +0.8% | +$8.42K | ﹤0.01% | 4110 |
|
|
2022
Q4 | $1.09M | Buy |
9,421
+4,859
| +107% | +$566K | ﹤0.01% | 3995 |
|
|
2022
Q3 | $495K | Buy |
4,562
+281
| +7% | +$40.3K | ﹤0.01% | 4352 |
|
|
2022
Q2 | $773K | Sell |
4,281
-23,771
| -85% | -$4.25M | ﹤0.01% | 3935 |
|
|
2022
Q1 | $4.79M | Sell |
28,052
-2,114
| -7% | -$399K | ﹤0.01% | 2585 |
|
|
2021
Q4 | $6.32M | Buy |
30,166
+23,324
| +341% | +$4.82M | ﹤0.01% | 2574 |
|
|
2021
Q3 | $1.32M | Sell |
6,842
-1,292
| -16% | -$318K | ﹤0.01% | 3946 |
|
|
2021
Q2 | $2.3M | Buy |
8,134
+519
| +7% | +$141K | ﹤0.01% | 3456 |
|
|
2021
Q1 | $1.61M | Sell |
7,615
-6,330
| -45% | -$1.51M | ﹤0.01% | 3782 |
|
|
2020
Q4 | $2.74M | Buy |
13,945
+3,398
| +32% | +$600K | ﹤0.01% | 3086 |
|
|
2020
Q3 | $1.74M | Buy |
10,547
+952
| +10% | +$157K | ﹤0.01% | 3180 |
|
|
2020
Q2 | $1.33M | Sell |
9,595
-2,033
| -17% | -$187K | ﹤0.01% | 3263 |
|
|
2020
Q1 | $727K | Sell |
11,628
-7,555
| -39% | -$688K | ﹤0.01% | 3638 |
|
|
2019
Q4 | $2.1M | Buy |
19,183
+7,826
| +69% | +$757K | ﹤0.01% | 3503 |
|
|
2019
Q3 | $1.18M | Buy |
11,357
+4,415
| +64% | +$475K | ﹤0.01% | 3821 |
|
|
2019
Q2 | $891K | Sell |
6,942
-40,055
| -85% | -$5.56M | ﹤0.01% | 3841 |
|
|
2019
Q1 | $5.99M | Buy |
46,997
+303
| +0.6% | +$38.4K | ﹤0.01% | 2068 |
|
|
2018
Q4 | $5.84M | Buy |
46,694
+42,344
| +973% | +$7.24M | ﹤0.01% | 2017 |
|
|
2018
Q3 | $963K | Sell |
4,350
-4,268
| -50% | -$865K | ﹤0.01% | 3883 |
|
|
2018
Q2 | $1.38M | Buy |
8,618
+6,578
| +322% | +$841K | ﹤0.01% | 3496 |
|
|
2018
Q1 | $190K | Buy |
2,040
+74
| +4% | +$5.53K | ﹤0.01% | 4816 |
|
|
2017
Q4 | $137K | Sell |
1,966
-1,580
| -45% | -$105K | ﹤0.01% | 5176 |
|
|
2017
Q3 | $211K | Buy |
3,546
+2,434
| +219% | +$121K | ﹤0.01% | 4807 |
|
|
2017
Q2 | $46K | Buy |
1,112
+487
| +78% | +$21.2K | ﹤0.01% | 5711 |
|
|
2017
Q1 | $28K | Buy |
625
+88
| +16% | +$3.79K | ﹤0.01% | 5909 |
|
|
2016
Q4 | $22K | Buy |
537
+2
| +0.4% | +$81 | ﹤0.01% | 6457 |
|
|
2016
Q3 | $20K | Sell |
535
-103
| -16% | -$3.69K | ﹤0.01% | 6290 |
|
|
2016
Q2 | $21K | Buy |
638
+43
| +7% | +$1.39K | ﹤0.01% | 6261 |
|
|
2016
Q1 | $18K | Sell |
595
-737
| -55% | -$21.5K | ﹤0.01% | 6287 |
|
|
2015
Q4 | $40K | Sell |
1,332
-477
| -26% | -$14.2K | ﹤0.01% | 6026 |
|
|
2015
Q3 | $48K | Buy |
1,809
+985
| +120% | +$28.7K | ﹤0.01% | 5880 |
|
|
2015
Q2 | $27K | Buy |
824
+298
| +57% | +$9.45K | ﹤0.01% | 6592 |
|
|
2015
Q1 | $16K | Hold |
526
| – | – | ﹤0.01% | 7209 |
|
|
2014
Q4 | $18K | Buy |
+526
| New | +$16.4K | ﹤0.01% | 7797 |
|
Other funds holding MED
SCP
VCM
